AU Patent

AU2025204271A1 — Microcrystalline diketopiperazine compositions and methods

Assigned to Mannkind Corp · Expires 2025-07-03 · 1y expired

What this patent protects

An inhaler comprising a pharmaceutical composition comprising: a crystalline diketopiperazine composition comprising a plurality of microcrystalline particles substantially uniform in size having a substantially hollow spherical structure and comprising a core and a shell compris…

USPTO Abstract

An inhaler comprising a pharmaceutical composition comprising: a crystalline diketopiperazine composition comprising a plurality of microcrystalline particles substantially uniform in size having a substantially hollow spherical structure and comprising a core and a shell comprising crystallites of the diketopiperazine that do not self assemble, wherein the particles have a volumetric median geometric diameter less than 5 μm.

Drugs covered by this patent

Patent Metadata

Patent number
AU2025204271A1
Jurisdiction
AU
Classification
—
Expires
2025-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Mannkind Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.